
### [MONDO:0015157](http://purl.obolibrary.org/obo/MONDO_0015157)
**Label:** human herpesvirus 8-related disorder

**Subclasses:** [MONDO:0007845](http://purl.obolibrary.org/obo/MONDO_0007845) (Kaposi sarcoma, susceptibility to), [MONDO:0015564](http://purl.obolibrary.org/obo/MONDO_0015564) (Castleman disease), [MONDO:0018842](http://purl.obolibrary.org/obo/MONDO_0018842) (primary effusion lymphoma), [MONDO:0019753](http://purl.obolibrary.org/obo/MONDO_0019753) (localized Castleman disease), [MONDO:0018049](http://purl.obolibrary.org/obo/MONDO_0018049) (Kaposi sarcoma), [MONDO:0019754](http://purl.obolibrary.org/obo/MONDO_0019754) (multicentric Castleman disease), [MONDO:0019752](http://purl.obolibrary.org/obo/MONDO_0019752) (pediatric Castleman disease), 

**Corr. equiv. classes:** [OMIM:148000](http://purl.obolibrary.org/obo/OMIM_148000), [Orphanet:33276](http://www.orpha.net/ORDO/Orphanet_33276), [Orphanet:93682](http://www.orpha.net/ORDO/Orphanet_93682), [Orphanet:48686](http://www.orpha.net/ORDO/Orphanet_48686), [Orphanet:160](http://www.orpha.net/ORDO/Orphanet_160), [Orphanet:93686](http://www.orpha.net/ORDO/Orphanet_93686), [Orphanet:93685](http://www.orpha.net/ORDO/Orphanet_93685), 

**Class expressions from DL-Learner:**

- [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 55.11%
- [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 55.11%
- [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) 43.15%
- [HP:0000969](http://purl.obolibrary.org/obo/HP_0000969) (Edema) and [HP:0001034](http://purl.obolibrary.org/obo/HP_0001034) (Hypermelanotic macule) 43.15%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 24.22%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) 23.09%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 22.31%
- Thing 22.31%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 22.31%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 19.76%
- [HP:0025142](http://purl.obolibrary.org/obo/HP_0025142) (Constitutional symptom) 16.89%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 16.68%
- [HP:0012252](http://purl.obolibrary.org/obo/HP_0012252) (Abnormal respiratory system morphology) 16.50%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 16.14%
- [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) 16.02%


